NSC |
Compound |
Enrichment |
Correlation |
NSC 728221 |
5,5-Dimethyl-3-[2-(2,3,5,6-tetrachloro-pyridin-4-ylsulfanyl) -vinyl]-cyclohex-2-enone |
0.000880521445136051 |
0.33407199 |
NSC 128687 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) |
0.000880521445136057 |
0.79209615 |
NSC 163424 |
4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- |
0.000931492155975089 |
0.40916493 |
NSC 673652 |
2-Ethylaminoestradiol |
0.000931492155975089 |
0.060241438 |
NSC 287459 |
Cytarabine AY |
0.00109467026514912 |
0.81776267 |
NSC 734294 |
Indenoisoquinoline derivative |
0.00119931827492062 |
0.49240107 |
NSC 740276 |
5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide |
0.00119931827492062 |
0.5869118 |
NSC 628906 |
3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Trifluoroacetate. |
0.00138752552318951 |
0.090646155 |
NSC 669382 |
Null |
0.00138752552318951 |
0.070958876 |
NSC 375162 |
Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide |
0.00180888338647612 |
0.36058995 |